| EPF109 | Influence of boarding secondary school environment on HIV positive students in South Western Uganda | E-poster | Stigma and key populations |
| EPD122 | Influence of descriptive network norms on injection behaviors among people who inject drugs during the COVID-19 pandemic: a latent profile analysis | E-poster | People who inject drugs |
| EPD181 | Influence of mandatory HIV testing policy on prenatal services seeking behavior among pregnant women in Nyamira North Sub-County Kenya | E-poster | Other populations vulnerable in specific contexts |
| PESUD45 | Influence of multiple stigmas on psychosocial problems and condom use among MSM and transgender women in India: findings from a longitudinal S3 (stigma, syndemics and sex) cohort study | Poster exhibition | Societal stigma towards people living with HIV and key populations |
| EPF081 | Influence of the proposed anti-LGBTQ+ bill on HIV&AIDS programs for men who have sex with men (MSM) in Ghana | E-poster | Gender equity and diversity |
| EPF013 | Influence of the voice of the community of women using drugs in Ukraine on decision-making related to policies and programs for HIV and TB prevention and treatment | E-poster | Laws, policies and practices impacting access to HIV testing, prevention, treatment, care and support |
| EPE210 | Information technology as an assistant in monitoring progress on transition, sustainability and co-financing of HIV in the countries of the EECA region | E-poster | Transitional financing |
| EPB231 | Inhibitory, KIR/HLA-mismatched, allogeneic NK and γδ-T cells as an HIV cure strategy: proof-of-concept in 3 patients | E-poster | Cure interventions |
| PESAB02 | In-hospital mortality among persons with HIV (PWH) in the US and Canada, 2005-2018 | Poster exhibition | Morbidity, mortality and life expectancy in clinical research |
| EPB179 | Initiating long-acting cabotegravir and rilpivirine in a real-world setting ' clinical characteristics and switch reasons from people living with HIV (PLHIV) and health care provider perspective in the German CARLOS cohort | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |